Finnish heritage disease
A Finnish heritage disease is a genetic disease or disorder that is significantly more common in people whose ancestors were ethnic Finns, natives of Finland and Sweden. About 40 rare diseases are regarded as Finnish heritage diseases. The diseases are not restricted to Finns; they are genetic diseases with far wider distribution in the world, but due to founder effects and genetic isolation they are more common in Finns.
Within Finland these diseases are more common in the east and north, consistent with their higher association with ethnic Finns than with ethnic Swedes. The Finnish disease heritage does not extend to other ethnic groups in the region, the Sámi and Karelians other than Finnish Karelians. It is attributed to a population bottleneck among ancestors of modern Finns, estimated to have occurred about 4000 years ago, presumably when populations practicing agriculture and animal husbandry arrived in Finland.
In Finland about one in five persons carries a gene defect associated with at least one Finnish heritage disease, and about one in 500 children born is affected. Most of the gene defects are autosomal recessives, so that if both the mother and father carry the same defect, the chance that their child will have the associated disease is 1 in 4. The molecular genetics of many of these diseases have been determined, enabling genetic testing, prenatal testing, and counseling. This has raised questions of bioethics and eugenics.
Finnish heritage disease
Finnish heritage diseases include:
- APECED (autoimmune polyendocrinopathy—candidiasis—ectodermal dystrophy)
- Aspartylglucosaminuria, a lysosomal storage disease
- Congenital adrenal hyperplasia
- Congenital nephrotic syndrome, a kidney disease of newborn babies
- Congenital chloride diarrhea
- Congenital stromal corneal dystrophy
- GRACILE syndrome
- Lethal arthrogryposis with anterior horn cell disease
- Lethal congenital contracture syndrome 1
- Meretoja syndrome
- Meckel syndrome
- Myotonia congenita
- Nonketotic hyperglycinemia
- Salla disease, a lysosomal storage disease
- PEHO syndrome
- Rapadilino syndrome
- Usher syndrome
Four genetically distinct subtypes of neuronal ceroid lipofuscinosis are found in the Finnish heritage: CLN1, CLN3, CLN5, and CLN8. Names for conditions associated with these subtypes include infantile neuronal ceroid lipofuscinosis, Jansky-Bielschowsky disease and northern epilepsy syndrome. As of 2001, CLN5 and CLN8 had been reported almost exclusively in Finland.
Other genetic diseases
The European Organization for Rare Diseases (EURORDIS) estimates that there are between 5,000 and 7,000 distinct rare diseases, affecting between 6% and 8% of the population of the European Union. The majority of genetic diseases reported in Finland are not part of the Finnish disease heritage and their prevalence is not higher in Finland than worldwide.
Some genetic diseases are disproportionately rare in Finns. These include cystic fibrosis and phenylketonuria. In Finland, about 1 in 80 persons are carriers of a cystic fibrosis mutation, compared with an average of 1 in 25 elsewhere in Europe.
Based on molecular data, a population bottleneck among ancestors of modern Finns is estimated to have occurred about 4000 years ago. This bottleneck resulted in exceptionally low diversity in the Y chromosome, estimated to reflect the survival of just two ancestral male lineages. The distribution of Y chromosome haplotypes within Finland is consistent with two separate founding settlements, in eastern and western Finland. The population bottleneck is seen only in the Y chromosome. Genetic diversity in autosomal chromosomes and in mitochondrial DNA (maternally inherited) is as high among Finns as among other European ethnic groups.
The Finnish disease heritage has been attributed to this 4000-year-old bottleneck. The geographic distribution and family pedigrees associated with some Finnish heritage disease mutations has linked the enrichment in these mutations to multiple local founder effects, some associated with a period of "late settlement" in the 16th century (see History of Finland).
Although the concept is older, the English term "Finnish disease heritage" first appears in the medical literature in the 1990s. One of the earliest uses is in the translated title of a 1994 medical article, soon followed by others.
- Leena Palotie
- Nine diseases
- Population genetics
- BCG disease outbreak in Finland in the 2000s
- Medical genetics of Ashkenazi Jews
- FAIDD (The Finnish Association on Intellectual and Developmental Disabilities)
- Finno-Ugrian suicide hypothesis
- Norio R (May 2003). "The Finnish Disease Heritage III: the individual diseases". Human Genetics 112 (5-6): 470–526. doi:10.1007/s00439-002-0877-1. PMID 12627297.
- Palo JU, Ulmanen I, Lukka M, Ellonen P, Sajantila A (April 2009). "Genetic markers and population history: Finland revisited". European Journal of Human Genetics 17 (10): 1336–46. doi:10.1038/ejhg.2009.53. PMC 2986642. PMID 19367325.
- Sajantila A, Salem AH, Savolainen P, Bauer K, Gierig C, Pääbo S (October 1996). "Paternal and maternal DNA lineages reveal a bottleneck in the founding of the Finnish population". Proceedings of the National Academy of Sciences of the United States of America 93 (21): 12035–9. doi:10.1073/pnas.93.21.12035. PMC 38178. PMID 8876258.
- Kallinen J, Heinonen S, Palotie A, Mannermaa A, Ryynanen M (May 2001). "Antenatal gene tests in low-risk pregnancies: molecular screening for aspartylglucosaminuria (AGU) and infantile neuronal ceroid lipofuscinosis (INCL) in Finland". Prenatal Diagnosis 21 (5): 409–12. doi:10.1002/pd.82. PMID 11360285.
- Seppo Poutanen (2005). "3: The first genetic screening in Finland: its execution, evaluation, and some possible implications for liberal government". In Robin Bunton and Alan Petersen. Genetic governance: Health, risk, and ethics in the biotech era. Routledge. p. 215. ISBN 0-415-35407-2.
- Levo A, Jääskeläinen J, Sistonen P, Sirén MK, Voutilainen R, Partanen J (1999). "Tracing past population migrations: genealogy of steroid 21-hydroxylase (CYP21) gene mutations in Finland". European Journal of Human Genetics 7 (2): 188–96. doi:10.1038/sj.ejhg.5200262. PMID 10196702.
- Lenkkeri U, Männikkö M, McCready P, Lamerdin J, Gribouval O, Niaudet PM, Antignac C K, Kashtan CE, Homberg C, Olsen A, Kestilä M, Tryggvason K (January 1999). "Structure of the gene for congenital nephrotic syndrome of the finnish type (NPHS1) and characterization of mutations". American Journal of Human Genetics 64 (1): 51–61. doi:10.1086/302182. PMC 1377702. PMID 9915943.
- Alajoki L, Varho T, Posti K, Aula P, Korhonen T (December 2004). "Neurocognitive profiles in Salla disease". Developmental Medicine and Child Neurology 46 (12): 832–7. doi:10.1111/j.1469-8749.2004.tb00449.x. PMID 15581157.
- Krystyna E. Wiśniewski, Nanbert Zhong, Jeffrey C. Hall (2001). Batten disease: diagnosis, treatment, and research. Academic Press. p. 243. ISBN 0-12-017645-9. page 125
- Consugar MB, Kubly VJ, Lager DJ, Hommerding CJ, Wong WC, Bakker E, Gattone VH, Torres VE, Breuning MH, Harris PC (June 2007). "Molecular diagnostics of Meckel–Gruber syndrome highlights phenotypic differences between MKS1 and MKS3". Human Genetics 121 (5): 591–9. doi:10.1007/s00439-007-0341-3. PMID 17377820.
- Salonen R; Opitz, John M.; Reynolds, James F. (August 1984). "The Meckel syndrome: clinicopathological findings in 67 patients". American Journal of Medical Genetics 18 (4): 671–89. doi:10.1002/ajmg.1320180414. PMID 6486167.
- "Rare Diseases: Understanding This Public Health Priority". European Organisation for Rare Diseases (EURORDIS). November 2005. Retrieved 16 May 2009.
- Hytönen M, Patjas M, Vento SI, Kauppi P, Malmberg H, Ylikoski J, Kere J (December 2001). "Cystic fibrosis gene mutations deltaF508 and 394delTT in patients with chronic sinusitis in Finland". Acta Oto-laryngologica 121 (8): 945–7. doi:10.1080/000164801317166835. PMID 11813900.
- Kittles RA, Bergen AW, Urbanek M, Virkkunen M, Linnoila M, Goldman D, Long JC (April 1999). "Autosomal, mitochondrial, and Y chromosome DNA variation in Finland: evidence for a male-specific bottleneck". American Journal of Physical Anthropology 108 (4): 381–99. doi:10.1002/(SICI)1096-8644(199904)108:4<381::AID-AJPA1>3.0.CO;2-5. PMID 10229384.
- Lahermo P, Savontaus ML, Sistonen P, Béres J, de Knijff P, Aula P, Sajantila A (1999). "Y chromosomal polymorphisms reveal founding lineages in the Finns and the Saami". European Journal of Human Genetics 7 (4): 447–58. doi:10.1038/sj.ejhg.5200316. PMID 10352935.
- Kittles RA, Perola M, Peltonen L, Bergen AW, Aragon RA, Virkkunen M, Linnoila M, Goldman D, Long JC (May 1998). "Dual origins of Finns revealed by Y chromosome haplotype variation". American Journal of Human Genetics 62 (5): 1171–9. doi:10.1086/301831. PMC 1377088. PMID 9545401.
- Peltonen L, Jalanko A, Varilo T (1999). "Molecular genetics of the Finnish disease heritage". Human Molecular Genetics 8 (10): 1913–23. doi:10.1093/hmg/8.10.1913. PMID 10469845.
- de la Chapelle A, Hästbacka J, Lehesjoki AE, Sulisalo T, Kere J, Tahvanainen E, Sistonen P (1994). "[Linkage and linkage disequilibrium in the Finnish disease heritage]". Duodecim; Lääketieteellinen Aikakauskirja (in Finnish) 110 (7): 654–64. PMID 8542820.
- Perheentupa J (October 1995). "The Finnish disease heritage: a personal look". Acta Paediatrica (Oslo, Norway : 1992) 84 (10): 1094–9. doi:10.1111/j.1651-2227.1995.tb13501.x. PMID 8563216.